A comparison of characteristics and outcomes in severe human metapneumovirus and respiratory syncytial virus infections in children treated in an intensive care unit

Pediatric Infectious Disease Journal

Volumn 32, Issue 12, 2013, Pages 1330-1334

  Eggleston, Heath A ^a   Gunville, Cameron F ^b   Miller, Joshua I ^c   Sontag, Marci K ^c   Mourani, Peter M ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Global Health and Health Disparities   (United States)

Author keywords

Bronchiolitis; Human metapneumovirus; Pediatric intensive care; Respiratory syncytial virus

Indexed keywords

ANTIGEN; BRONCHODILATING AGENT; OXYGEN; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONGENITAL HEART DISEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEVERE HUMAN METAPNEUMOVIRUS INFECTION; STAIN; BRONCHIOLITIS, VIRAL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; ISOLATION AND PURIFICATION; LENGTH OF STAY; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TREATMENT OUTCOME; VIROLOGY;

BRONCHIOLITIS, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; METAPNEUMOVIRUS; PARAMYXOVIRIDAE INFECTIONS; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84891741190     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182a2261b     Document Type: Article

References (23)

1. Hall CB. respiratory syncytial virus and parainfuenza virus. N Engl J Med. 2001;344:1917-1928
2. Treanor J. respiratory infections. in: richmann dd WR, Hayden FG, eds. Clinical Virology. 1st ed. new York, nY: Churchill living-stone; 1997:5-33.
3. Buckingham SC, Quasney M W, Bush AJ, et al. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med. 2001;2:318-323.
4. Papenburg J, Boivin G. the distinguishing features of human metapneumo-virus and respiratory syncytial virus. Rev Med Virol. 2010;20:245-260.
5. Sung CC, Chi H, Chiu NC, et al. Viral etiology of acute lower respiratory tract infections in hospitalized young children in northern taiwan. J Microbiol Immunol Infect. 2011;44:184-190.
6. Van Den Hoogen BG, De JONG JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719-724.
7. Edwards KM, Zhu Y, Griffn MR, et al.; New vaccine surveillance network. burden of human metapneumovirus infection in young children. N Engl J Med. 2013;368:633-643.
8. Beneri C, Ginocchio CC, Manji R, et al. Comparison of clinical features of pediatric respiratory syncytial virus and human metapneumovirus infections. Infect Control Hosp Epidemiol. 2009;30:1240-1241.
9. Boivin G, Hamelin M-È, Abed Y. Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis. 2004;38:983-990.
10. Williams J V, Harris PA, Tollefson SJ, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-450.
11. Morrow BM, Hatherill M, Smuts HE, et al. Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus. J Paediatr Child Health. 2006;42:174-178.
12. Mullins JA, Erdman DD, Weinberg GA, et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis. 2004;10:700-705.
13. Paget S P, Andresen DN, Kesson AM, et al. Comparison of human metap-neumovirus and respiratory syncytial virus in children admitted to a paedi-atric intensive care unit. J Paediatr Child Health. 2011;47:737-741.
14. Wilkesmann A, Schildgen O, Eis-Hübinger AM, et al. Human metapneumo-virus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections. Eur J Pediatr. 2006;165:467-475.
15. Wolf DG, Greenberg D, Kalkstein D, et al. Comparison of human metap-neumovirus, respiratory syncytial virus and infuenza a virus lower respiratory tract infections in hospitalized young children. Pediatr Infect Dis J. 2006;25:320-324.
16. Baer G, Schaad UB, Heininger U. Clinical fndings and unusual epidemio-logic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland. Eur J Pediatr. 2008;167:63-69.
17. Van Den Hoogen BG, Van Doornum GJ, Fockens JC, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis. 2003;188:1571-1577.
18. Zhang SX, Tellier R, Zafar R, et al. Comparison of human metapneumovi-rus infection with respiratory syncytial virus infection in children. Pediatr Infect Dis J. 2009;28:1022-1024.
19. Anderson EJ, Simoes EAF, Buttery J P, et al. Prevalence and characteristics of human metapneumovirus infection among hospitalized children at high risk for severe lower respiratory tract infection. J Pediatric Infect Dis Soc. 2012;1:212-222.
20. Martin JA, Osterman MJK, Sutton PD. are preterm births on the decline in the united States? recent data from the national Vital Statistics System. NCHS Data Brief. 2010;39:1-8.
21. Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2012;130:91-100 e103.
22. García-García ML, Calvo C, Casas I, et al. Human metapneumovirus bron-chiolitis in infancy is an important risk factor for asthma at age 5. Pediatr Pulmonol. 2007;42:458-464.
23. Greensill J, Mcnamara PS, Dove W, et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis. 2003;9:372-375.